Treatment of choice in hypeension with diabetes mellitus is
**Core Concept**
The management of hypertension in patients with diabetes mellitus requires a multifaceted approach that takes into account the pathophysiology of both conditions. The primary goal is to reduce blood pressure and prevent cardiovascular complications, while also managing glycemic control and other metabolic factors.
**Why the Correct Answer is Right**
The treatment of choice in hypertension with diabetes mellitus is often a combination of lifestyle modifications and pharmacotherapy. **Option D**, ACE inhibitors or angiotensin receptor blockers (ARBs), are generally recommended as first-line agents due to their ability to lower blood pressure, reduce proteinuria, and slow the progression of diabetic nephropathy. This is because ACE inhibitors and ARBs have been shown to have a protective effect on the kidneys by reducing intraglomerular pressure and decreasing the levels of angiotensin II, a potent vasoconstrictor.
**Why Each Wrong Option is Incorrect**
* **Option A:** Diuretics, such as hydrochlorothiazide, may be used as add-on therapy but are not the preferred initial treatment due to their potential to worsen glucose tolerance and increase the risk of hypokalemia.
* **Option B:** Beta-blockers, such as atenolol, may be used in certain cases, but they are not the preferred initial treatment in patients with diabetes mellitus due to their potential to mask symptoms of hypoglycemia and worsen glucose tolerance.
* **Option C:** Calcium channel blockers, such as amlodipine, may be used as add-on therapy but are not the preferred initial treatment due to their potential to worsen glucose tolerance and increase the risk of edema.
**Clinical Pearl / High-Yield Fact**
In patients with hypertension and diabetes mellitus, it is essential to use medications that have a protective effect on the kidneys and do not worsen glycemic control. ACE inhibitors and ARBs are the preferred initial treatment due to their ability to reduce proteinuria and slow the progression of diabetic nephropathy.
**Correct Answer:** D. ACE inhibitors or ARBs.